The overexpression and amplification of the MDM2 oncogene frequently occur in breast cancer, correlating with high tumor grade and serving as an independent negative prognostic marker in human breast cancer (Jiang et al., 1997; Turbin et al., 2006). This evidence concerns the gene MDM2 and breast carcinoma.